Published in J Chromatogr B Analyt Technol Biomed Life Sci on January 06, 2009
Endogenous generation and protective effects of nitro-fatty acids in a murine model of focal cardiac ischaemia and reperfusion. Cardiovasc Res (2010) 1.58
Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions. J Biol Chem (2010) 1.57
Characterization and quantification of endogenous fatty acid nitroalkene metabolites in human urine. J Lipid Res (2013) 1.06
PPARs and lipid ligands in inflammation and metabolism. Chem Rev (2011) 1.06
Electrophilic nitro-fatty acids inhibit vascular inflammation by disrupting LPS-dependent TLR4 signalling in lipid rafts. Cardiovasc Res (2013) 1.01
Signaling actions of electrophiles: anti-inflammatory therapeutic candidates. Mol Interv (2010) 0.93
Gas-phase fragmentation analysis of nitro-fatty acids. J Am Soc Mass Spectrom (2011) 0.86
Nitro-oleic acid modulates classical and regulatory activation of macrophages and their involvement in pro-fibrotic responses. Free Radic Biol Med (2015) 0.83
Nitroalkene fatty acids mediate activation of Nrf2/ARE-dependent and PPARγ-dependent transcription by distinct signaling pathways and with significantly different potencies. Biochemistry (2011) 0.81
Evaluation of 10-Nitro Oleic Acid Bio-Elimination in Rats and Humans. Sci Rep (2017) 0.76
Nitro-fatty acids in cardiovascular regulation and diseases: characteristics and molecular mechanisms. Front Biosci (Landmark Ed) (2016) 0.76
Nitro-oleic acid and epoxyoleic acid are not altered in obesity and type 2 diabetes: reply. Cardiovasc Res (2014) 0.75
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series. Hypertension (2012) 6.70
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res (2011) 3.88
Activation of the peripheral endocannabinoid system in human obesity. Diabetes (2005) 2.90
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes (2006) 2.40
Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension (2010) 2.38
Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation (2004) 2.20
Retinol-binding protein 4 in human obesity. Diabetes (2006) 2.17
The SCF-FBXW5 E3-ubiquitin ligase is regulated by PLK4 and targets HsSAS-6 to control centrosome duplication. Nat Cell Biol (2011) 1.99
The sympathetic nervous system in hypertension: assessment by blood pressure variability and ganglionic blockade. J Hypertens (2003) 1.98
Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice. Cell Metab (2011) 1.98
Contribution of endothelial nitric oxide to blood pressure in humans. Hypertension (2006) 1.85
Autonomic nervous system and blood pressure regulation in RGS2-deficient mice. Am J Physiol Regul Integr Comp Physiol (2005) 1.84
Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol (2010) 1.82
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci (2011) 1.82
Water ingestion as prophylaxis against syncope. Circulation (2003) 1.76
Women have lower tonic autonomic support of arterial blood pressure and less effective baroreflex buffering than men. Circulation (2005) 1.75
Plasma exchange for primary autoimmune autonomic failure. N Engl J Med (2005) 1.71
The BK channel beta1 subunit gene is associated with human baroreflex and blood pressure regulation. J Hypertens (2002) 1.65
Water drinking as a treatment for orthostatic syndromes. Am J Med (2002) 1.60
Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects. Clin Pharmacol Ther (2006) 1.59
Sodium paradoxically reduces the gastropressor response in patients with orthostatic hypotension. Hypertension (2006) 1.51
Aliskiren penetrates adipose and skeletal muscle tissue and reduces renin-angiotensin system activity in obese hypertensive patients. J Hypertens (2012) 1.50
A genetic basis for mechanosensory traits in humans. PLoS Biol (2012) 1.50
Weight neutrality with the DPP-4 inhibitor, vildagliptin: mechanistic basis and clinical experience. Vasc Health Risk Manag (2010) 1.45
Peripheral chemoreflex regulation of sympathetic vasomotor tone in apnea divers. Clin Auton Res (2009) 1.42
Riluzole and blood pressure in multiple system atrophy. Clin Auton Res (2003) 1.39
The Valsalva maneuver: screening for drug-induced baroreflex dysfunction. Clin Auton Res (2008) 1.38
Dipeptidyl-peptidase-IV inhibition augments postprandial lipid mobilization and oxidation in type 2 diabetic patients. J Clin Endocrinol Metab (2008) 1.36
Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans. J Clin Endocrinol Metab (2005) 1.32
Natriuretic peptides enhance the oxidative capacity of human skeletal muscle. J Clin Invest (2012) 1.32
Atrial natriuretic peptide induces postprandial lipid oxidation in humans. Diabetes (2008) 1.25
Water drinking acutely improves orthostatic tolerance in healthy subjects. Circulation (2002) 1.25
Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects. Hepatology (2011) 1.23
Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe. Br J Clin Pharmacol (2011) 1.20
Adipose tissue metabolism and CD11b expression on monocytes in obese hypertensives. Hypertension (2005) 1.19
Cardiovascular regulation during apnea in elite divers. Hypertension (2009) 1.19
Baroreflex buffering is reduced with age in healthy men. Circulation (2003) 1.13
Diabetic hypertensive leptin receptor-deficient db/db mice develop cardioregulatory autonomic dysfunction. Hypertension (2008) 1.12
Water-induced thermogenesis. J Clin Endocrinol Metab (2003) 1.11
Baroreflex regulation of heart rate and sympathetic vasomotor tone in women and men. Hypertension (2005) 1.11
Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance. Circulation (2002) 1.11
Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). J Cachexia Sarcopenia Muscle (2010) 1.10
Regulator of G protein signalling 2 ameliorates angiotensin II-induced hypertension in mice. Exp Physiol (2007) 1.09
Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-gamma activation. J Hypertens (2006) 1.08
Water drinking induces thermogenesis through osmosensitive mechanisms. J Clin Endocrinol Metab (2007) 1.07
Baroreflex failure. Hypertension (2005) 1.06
Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: a comprehensive review from an analytical and biological perspective. Biochim Biophys Acta (2011) 1.05
The molecular and cellular identity of peripheral osmoreceptors. Neuron (2011) 1.05
Heart rate variability and baroreflex function in AT2 receptor-disrupted mice. Hypertension (2002) 1.04
Nitro-fatty acids occur in human plasma in the picomolar range: a targeted nitro-lipidomics GC-MS/MS study. Lipids (2009) 1.04
Blood oxygen level-dependent MRI of tissue oxygenation: relation to endothelium-dependent and endothelium-independent blood flow changes. Arterioscler Thromb Vasc Biol (2005) 1.02
Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition. Circulation (2003) 1.01
Myocardial steatosis, cardiac remodelling and fitness in insulin-sensitive and insulin-resistant obese women. Heart (2011) 1.00
Development and validation of an efficient HPLC method for quantification of voriconazole in plasma and microdialysate reflecting an important target site. Anal Bioanal Chem (2008) 1.00
Niacin lowers serum phosphate and increases HDL cholesterol in dialysis patients. Clin J Am Soc Nephrol (2007) 1.00
Autonomic cardiovascular and respiratory control during prolonged spaceflights aboard the International Space Station. J Appl Physiol (1985) (2007) 0.99
Portal osmopressor mechanism linked to transient receptor potential vanilloid 4 and blood pressure control. Hypertension (2010) 0.99
CD81 is essential for the formation of membrane protrusions and regulates Rac1-activation in adhesion-dependent immune cell migration. Blood (2011) 0.99
Modulation of QT interval during autonomic nervous system blockade in humans. Circulation (2002) 0.98
Quantitative determination of circulating and urinary asymmetric dimethylarginine (ADMA) in humans by gas chromatography-tandem mass spectrometry as methyl ester tri(N-pentafluoropropionyl) derivative. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 0.97
Influences of normobaric hypoxia training on physical fitness and metabolic risk markers in overweight to obese subjects. Obesity (Silver Spring) (2009) 0.97
Simultaneous UPLC-MS/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: minimization of matrix-effects, 2AG/1AG isomerization and degradation by toluene solvent extraction. J Chromatogr B Analyt Technol Biomed Life Sci (2011) 0.96
Beta-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation. J Clin Endocrinol Metab (2006) 0.95
Cardiorespiratory fitness and insulin sensitivity in overweight or obese subjects may be linked through intrahepatic lipid content. Diabetes (2010) 0.95
Influences of normobaric hypoxia training on metabolic risk markers in human subjects. Med Sci Sports Exerc (2008) 0.93
Atrial natriuretic peptide and adiponectin interactions in man. PLoS One (2012) 0.92
Good vibrations and strong bones? Am J Physiol Regul Integr Comp Physiol (2005) 0.92
European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions. J Hypertens (2009) 0.91
Role of the multidomain protein spinophilin in blood pressure and cardiac function regulation. Hypertension (2008) 0.91
Paradoxical effect of sibutramine on autonomic cardiovascular regulation. Circulation (2002) 0.91
Long-lasting improvements in liver fat and metabolism despite body weight regain after dietary weight loss. Diabetes Care (2013) 0.91
Cardiac magnetic resonance imaging during pulmonary hyperinflation in apnea divers. Med Sci Sports Exerc (2011) 0.90
Investigation of laser-induced choroidal neovascularization in the rat. Invest Ophthalmol Vis Sci (2003) 0.90
The osmopressor response to water drinking. Am J Physiol Regul Integr Comp Physiol (2010) 0.89
Cardiovascular autonomic regulation in Non-Obese Diabetic (NOD) mice. Auton Neurosci (2007) 0.88
Yohimbine attenuates baroreflex-mediated bradycardia in humans. Hypertension (2007) 0.88
In vivo response to alpha(1)-adrenoreceptor stimulation in human white adipose tissue. Obes Res (2002) 0.88
Xenotransplantation of retinal pigment epithelial cells into RCS rats. Jpn J Ophthalmol (2002) 0.87
GC-MS determination of creatinine in human biological fluids as pentafluorobenzyl derivative in clinical studies and biomonitoring: Inter-laboratory comparison in urine with Jaffé, HPLC and enzymatic assays. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.87
LMNA mutations, skeletal muscle lipid metabolism, and insulin resistance. J Clin Endocrinol Metab (2010) 0.87
Clonidine improves spontaneous baroreflex sensitivity in conscious mice through parasympathetic activation. Hypertension (2004) 0.87
Autosomal-dominant hypertension with type E brachydactyly is caused by rearrangement on the short arm of chromosome 12. Hypertension (2004) 0.87
Physiological phenomenology of neurally-mediated syncope with management implications. PLoS One (2011) 0.87
European Society of Hypertension Working Group on Obesity Antihypertensive effects of weight loss: myth or reality? J Hypertens (2010) 0.86
Hormonal influences on cardiovascular norepinephrine transporter responses in healthy women. Hypertension (2008) 0.86
The endocannabinoid system: body weight and metabolic regulation. Clin Cornerstone (2006) 0.86
Influences of norepinephrine transporter function on the distribution of sympathetic activity in humans. Hypertension (2006) 0.86
Water drinking improves orthostatic tolerance in patients with posturally related syncope. Clin Sci (Lond) (2006) 0.85
Targeted stable-isotope dilution GC-MS/MS analysis of the endocannabinoid anandamide and other fatty acid ethanol amides in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.85
More reasons doing less in syncope patients. Clin Auton Res (2006) 0.85
Influences of gender on the interaction between sympathetic nerve traffic and central adiposity. J Clin Endocrinol Metab (2008) 0.85
Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers. Kidney Int (2005) 0.84
Oxidized and nitrated oleic acid in biological systems: analysis by GC-MS/MS and LC-MS/MS, and biological significance. Biochim Biophys Acta (2011) 0.84
Heritability of venous function in humans. Arterioscler Thromb Vasc Biol (2003) 0.84
New developments in the pathogenesis of obesity-induced hypertension. J Hypertens (2015) 0.84